TRex Bio TRXB
TRex Bio initiates IPO
Securities offering
- Form
- 424B4
- Filed
- Importance
- Routine
- Accession
- 0001193125-26-419203
- Sells 8,333,334 shares of common stock
- IPO price of $14.00 per share
- Shares listed on Nasdaq under TRXB
- Eli Lilly interested in buying up to 19.9% of shares
Written from the 424B4 on EDGAR. Check the filing before you rely on it.
Similar companies
Same SIC code (2836) and public float not reported.
- Adaptimmune Therapeutics ADAP
- Adverum Biotechnologies ADVM
- AgomAb Therapeutics AGMB
- Alvotech ALVO
- Argenx ARGX